2 Deaths Linked to Experimental Alzheimer’s Treatment Lecanemab

Image: Shutterstock (Shutterstock) An experimental treatment for Alzheimer’s disease may pose a life-threatening risk of brain bleeding for certain patients, an investigative report out this week suggests. paper, published Monday in the journal Science, details the case of a 65-year-old woman who died from massive hemorrhaging that could have arisen from taking a common blood …

2 Deaths Linked to Experimental Alzheimer’s Treatment Lecanemab Read More »